US Stock MarketDetailed Quotes

ADILW Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)

Watchlist
  • 0.0009
  • 0.00000.00%
Close Jul 28 09:30 ET
0Market Cap0.00P/E (TTM)

About Adial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com) Company

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

Company Profile

SymbolADILW
Company NameAdial Pharmaceuticals Inc C/ Wts 31/07/2023 (To Pur Com)
CEOMr. Cary J Claiborne
MarketNASDAQ
Employees20
Fiscal Year Ends12-31
Websitehttps://www.adialpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Cary J Claiborne
  • Director, President and Chief Executive Officer
  • --
  • William B. Stilley, III,M.B.A.
  • Executive Vice President and Director; Chief Executive Officer of Purnovate, Inc.
  • --
  • Joseph Truluck, M.B.A.
  • Principal Accounting Officer, Chief Financial Officer, Treasurer and Secretary
  • --
  • Dr. Bankole A. Johnson, D.Sc.,M.D.
  • Chief Medical Officer
  • --
  • Kevin Schuyler, C.F.A.,M.B.A.
  • Chairman of the Board and Lead Independent Director
  • --
  • J. Kermit Anderson
  • Independent Director
  • --
  • James W. Newman, Jr
  • Independent Director
  • --
  • Tony Goodman
  • Independent Director
  • --
  • Robertson H. Gilliland, M.B.A.
  • Independent Director
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data